Biodesix (BDSX) Total Liabilities (2019 - 2026)

Biodesix has reported Total Liabilities for 8 years, with the latest figure at $85.5 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities rose 13.73% year-over-year to $85.5 million; the trailing twelve-month figure through Mar 2026 stood at $85.5 million (up 13.73% YoY), and the FY2025 full-year result was $89.9 million, up 17.77% from the prior year.
• Total Liabilities for Q1 2026 stood at $85.5 million, down from $89.9 million in the prior quarter.
• The five-year high for Total Liabilities was $94.5 million in Q4 2023, with the low at $53.9 million in Q1 2022.
• Historically, Total Liabilities has averaged $79.7 million across 5 years, with a median of $79.6 million in 2024.
• Annual changes were most pronounced in 2022 — Total Liabilities tumbled 31.86% — and 2023, when it surged 41.53%.
• Biodesix's Total Liabilities stood at $72.3 million in 2022, then jumped by 30.73% to $94.5 million in 2023, then retreated by 19.2% to $76.4 million in 2024, then rose by 17.77% to $89.9 million in 2025, then dropped by 4.93% to $85.5 million in 2026.
• The last three Total Liabilities figures came in at $85.5 million (Q1 2026), $89.9 million (Q4 2025), and $90.4 million (Q3 2025), per Business Quant data.